These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Orphan drugs: drugs for rare diseases]. Schenk M Dtsch Med Wochenschr; 2010 May; 135(18):p17. PubMed ID: 20455291 [No Abstract] [Full Text] [Related]
7. HHS defends expanded 340B drug discounts. Lee J Mod Healthc; 2014 Jun; 44(24):9. PubMed ID: 25137989 [No Abstract] [Full Text] [Related]
8. Access to orphan drugs in Europe: current and future issues. Michel M; Toumi M Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):23-9. PubMed ID: 22280193 [TBL] [Abstract][Full Text] [Related]
9. The challenges of orphan drugs and orphan diseases: real and imagined. Hudson I; Breckenridge A Clin Pharmacol Ther; 2012 Aug; 92(2):151-3. PubMed ID: 22814659 [TBL] [Abstract][Full Text] [Related]
10. The balancing act of orphan drug pricing. The Lancet Lancet; 2017 Dec; 390(10113):2606. PubMed ID: 29256396 [No Abstract] [Full Text] [Related]
11. [Orphan drugs: towards an economic evaluation]. Holué C Rev Prat; 2012 Jan; 62(1):91-4. PubMed ID: 22335077 [No Abstract] [Full Text] [Related]
12. Rare diseases and effective treatments: are we delivering? Luzzatto L; Hollak CE; Cox TM; Schieppati A; Licht C; Kääriäinen H; Merlini G; Schaefer F; Simoens S; Pani L; Garattini S; Remuzzi G Lancet; 2015 Feb; 385(9970):750-2. PubMed ID: 25752159 [No Abstract] [Full Text] [Related]
13. Support system: through charities, drug makers help people--and themselves. Anand G Wall St J (East Ed); 2005 Dec; ():A1, A10. PubMed ID: 16502554 [No Abstract] [Full Text] [Related]
14. Should off-label drug use be off-the-table? Rivkees SA J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432 [No Abstract] [Full Text] [Related]
16. [From drug cost to drug price: steps and decisional processes]. Bruyninckx M; Nourissier C Presse Med; 2012 May; 41 Suppl 1():S40-3. PubMed ID: 22487715 [No Abstract] [Full Text] [Related]